142 related articles for article (PubMed ID: 26108458)
41. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
42. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite.
Zheng H; Wang LM; Bao F; Jiang GN; Xie HK; Ding JA; Hu XF; Chen C
Lung Cancer; 2011 Dec; 74(3):497-503. PubMed ID: 21529990
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
44. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
[TBL] [Abstract][Full Text] [Related]
45. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
47. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
48. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
49. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
[TBL] [Abstract][Full Text] [Related]
50. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
51. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
52. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Zhao F; Ding G; Huang W; Li M; Fu Z; Yang G; Kong L; Zhang Y; Yu J
Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696
[TBL] [Abstract][Full Text] [Related]
53. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan.
Koike T; Tsuchiya R; Goya T; Sohara Y; Miyaoka E
J Thorac Oncol; 2007 May; 2(5):408-13. PubMed ID: 17473656
[TBL] [Abstract][Full Text] [Related]
55. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
[TBL] [Abstract][Full Text] [Related]
56. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
58. Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries.
O'Dowd EL; Lüchtenborg M; Baldwin DR; McKeever TM; Powell HA; Møller H; Jakobsen E; Hubbard RB
Lung Cancer; 2016 May; 95():88-93. PubMed ID: 27040857
[TBL] [Abstract][Full Text] [Related]
59. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer.
Tan JH; Tan KA; Zaw AS; Thomas AC; Hey HW; Soo RA; Kumar N
Spine (Phila Pa 1976); 2016 Apr; 41(7):638-44. PubMed ID: 27018903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
